Archive for May, 2008

OMNI Postings of 5/31/08

Joke of the Day from Comedy Central:  A guy was seated next to a 10-year-old girl on an airplane. Being bored, he turned to the girl and said, “Let’s talk. I’ve heard that flights go quicker if you strike up a conversation with your fellow passenger.”

The girl, who was reading a book, closed it slowly and said to the guy, “What would you like to talk about?”

Oh, I don’t know,” said the guy. “How about nuclear power?”

“OK,” she said. “That could be an interesting topic. But let me ask you a question first. A horse, a cow and a deer all eat the same stuff… grass. Yet a deer excretes little pellets, while a cow turns out a flat patty, and a horse produces clumps of dried grass. Why do you suppose that is?”

The guy thought about it and said, “Hmmm, I have no idea.”

To which the girl replied, “Do you really feel qualified to discuss nuclear power when you don’t know s**t?”  

But I digress…

1)  This contains the complete link to MMWR for the use of DTP in pregnancy, lactating women, and kiddies.
http://omniphysicians.com/2008/05/31/dtp-for-pregnant-and-postpartum-women-infants/

2)  VIP is being recalled because this is another one of those ahem…”virility” supplements that contains a sildenafil-like compound.  Maybe you old movie aficionados will remember that Rock Hudson concocted a product called “VIP” in one of his “bedroom” comedies with Doris Day. 
http://omniphysicians.com/2008/05/31/veto-on-vip/
3)  This is another up-to-date reminder from the FDA that CFC albuterol inhalers will no longer be sold by Dec. 31, 2008 and will have to be replaced by HFA inhalers.  HFA propelled albuterol inhalers may taste and feel different than the CFC propelled albuterol inhalers.  Notably, the force of the spray of an HFA propelled inhaler may feel softer than that of a CFC propelled inhaler.  Because of the perceptible change, patients may not use the product as directed and may not get the full effect.  We may need to have respiratory techs provide specific education for those wheezing patients.
http://omniphysicians.com/2008/05/31/fda-on-the-phasing-out-of-cfc-albuterol-inhalers/
4)  A MedScape case report in a young lady with sudden syncope.  There’s a characteristic EKG included.  No, she didn’t swoon just because Mierz walked by.
http://omniphysicians.com/2008/05/31/sudden-loc/

DTP for Pregnant and Postpartum Women & Infants

Prevention of Pertussis, Tetanus,
and Diphtheria Among Pregnant
and Postpartum Women
and their Infants

Recommendations of the Advisory Committee
on Immunization Practices (ACIP)
 
In 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines
were licensed in the United States for single-dose use in adults and adolescents to protect against pertussis and to replace the next dose of tetanus and diphtheria toxoids vaccine (Td). This report describes the clinical features of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants, reviews available evidence of pertussis vaccination during pregnancy
as a strategy to prevent infant pertussis, summarizes Tdap vaccination policy in the United States, and presents recommendations
for use of Td and Tdap vaccines
among pregnant and postpartum women.
full textfull text
Appendix A
Summary of ACIP Recommendations for Prevention of Pertussis, Tetanus and Diphtheria
Among Pregnant and Postpartum Women
and Their Infants
full textfull text
Appendix B
Abbreviations Used in This Report
full textfull text

Veto on VIP

International Pharmaceuticals, Ltd. and FDA notified consumers and healthcare professionals that the company is recalling all supplement products sold under the brand name of Viril-ity Power (VIP) Tablets.

The product is being recalled because one lot was found to contain a potentially harmful undeclared ingredient, hydroxyhomosildenafil, an analog of sildenafil. Sildenafil is the active ingredient in Viagra, an FDA-approved drug used for erectile dysfunction. The undeclared ingredient may interact with nitrates found in some prescription drugs ( such as Nitroglycerin) and may lower blood pressure to life-threatening levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take such nitrates. Consumers who have Viril-ity Power (VIP) Tablets should stop using it immediately and contact their healthcare professional if they experience any problems that may be related to taking this product.

Read the entire 2008 MedWatch Safety Summary, including a link to the manufacturer’s press release regarding this issue at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#VIP

FDA on the phasing out of CFC albuterol inhalers

 The Division of Drug Information (DDI) is CDER’s focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA. 

 

FDA is alerting patients, caregivers, and healthcare professionals to important information about albuterol inhalers. As part of a multi-year phase out, chlorofluorocarbon (CFC) propelled albuterol inhalers will not be available after December 31, 2008.  Healthcare professionals should transition patients to the hydrofluoralkane (HFA) propelled albuterol inhalers now. 

There are three HFA propelled albuterol inhalers that have been approved by the FDA: Proair HFA Inhalation Aerosol, Proventil HFA Inhalation Aerosol, and Ventolin HFA Inhalation Aerosol. Also FDA-approved is Xopenex HFA Inhalation Aerosol, an HFA propelled inhaler containing levalbuterol (the active form of albuterol).

HFA propelled albuterol inhalers may taste and feel different than the CFC propelled albuterol inhalers.  Notably, the force of the spray of an HFA propelled inhaler may feel softer than that of a CFC propelled inhaler.  It is important to remember that it is the deep breath that you take with each puff that gets the medication into your lungs, not the force of the spray. It is important to prime and clean the HFA propelled inhalers to prevent blockage in the inhaler device that will prevent the medicine from reaching the lungs.  Each HFA propelled inhaler has different priming, cleaning, and drying instructions.  Therefore, it is important to read and understand the instructions that come with each of the HFA propelled albuterol inhalers before using.

The labeling and instructions for the inhalers may be accessed at: http://dailymed.nlm.nih.gov/dailymed/about.cfm

The national transition from CFC propelled to HFA propelled albuterol inhalers is due to an international environmental treaty called the Montreal Protocol on Substances that Deplete the Ozone Layer.  Under this treaty, the United States has agreed to phase out production and importation of Ozone Depleting Substances (ODS) including CFCs.  Several CFC propelled inhalers containing other medicines have already been phased out.  Over the next several years, other CFC propelled inhalers will be phased out.

If after following the instructions that come with each of the HFA propelled albuterol inhalers you feel the product is not effective or causing you to experience side effects we urge you to report to FDA’s MedWatch program. MedWatch is a voluntary system of reporting to FDA any adverse effects and/or product problems. You can find a link to the Internet voluntary reporting form by going to the MedWatch homepage (http://www.fda.gov/medwatch/index.html),   click on “How to Report”, then “Reporting by Health Professionals” or “Reporting by Consumers”.

You can find more information at http://www.fda.gov/cder/mdi/albuterol.htm

Cyanide Poisoning

http://www.medscape.com/viewprogram/9018?src=nlcmealert&spon=45&uac=78937HJ

Contents of This CME Activity

  1. Prehospital Recognition and Management of Cyanide Poisoning in Smoke Inhalation VictimsAvailable As: Slides/Audio | Slides/Transcript | Audio
  2. Emergency Physicians’ Role in Appropriate Treatment of Cyanide Poisoning in Smoke Inhalation CasesAvailable As: Slides/Audio | Slides/Transcript | Audio
  3. Different Treatment Strategies for Smoke Inhalation in the Burn UnitAvailable As: Slides/Audio | Slides/Transcript | Audio
  4. Question and Answer SessionAvailable As: Slides/Audio | Slides/Transcript | Audio
Go to CME Test Questions

Sudden LOC

A 26-Year-Old Female Presents with Sudden Loss of Consciousness While Standing (http://www.medscape.com/viewprogram/12658_pnt)

 

Initial Presentation
Chief Complaint: Syncope
History of Present Illness: Sudden loss of consciousness while standing.
Duration: Single episode.

History
Past Medical History: Congenital heart anomaly; patient unaware of details
Family History: Hypertension

Physical Findings
Age: 26
Gender: Female
Blood Pressure: 108/76 mm Hg
Pulse: 50 bpm
Respiration: 16
General Appearance: Healthy appearing
Cardiac Exam: Variable S1, normal S2

1

The correct answer is: “Congenital third-degree AV block”

At first glance, the correct diagnosis appears to be 2:1 AV block. If one looks carefully at the lead II rhythm strip, one sees a slightly variable relationship between the “conducted” P wave and the next QRS complex. Specifically, the “PR” interval preceding the second and especially the third QRS complexes is short. If this were truly 2:1 second-degree AV block, the PR interval of each conducted beat would be identical. Since this cannot be 2:1 AV block, this must be complete AV block, with an atrial rate double the ventricular rate, and fortuitous timing, which simulates AV conduction. High-grade AV block generally refers to 3:1 (or greater) AV conduction.

Given the history, this patient likely has congenital complete AV block. In these patients, block is generally at the AV nodal level, resulting in a narrow and relatively sufficient escape rhythm.

Pacing is indicated for any patient with congenital heart block and associated symptoms (syncope, near syncope, exercise intolerance, etc). Electrophysiology testing does not add prognostic information. In addition, survival appears to be better in congenital heart block patients who receive pacemakers compared with nonpaced patients. This has made many cardiologists more aggressive in recommending pacemakers even to asymptomatic patients with a reasonable escape rate, though this remains a class IIb indication.

Note that the PP intervals alternate (long, short, long, short, etc.).

Ventriculophasic sinus arrhythmia can be seen with second- and third-degree AV block. This pattern is manifested by a shorter PP interval between P waves that “bracket” a QRS complex, compared to a longer PP interval between consecutive P waves without an intervening QRS complex. The mechanism is uncertain; one potential explanation is ventricular contraction causing stretch of the sinoatrial (SA) node and/or increased perfusion via the SA nodal artery.

Best Children’s Hospitals

This will take you to the best children’s hospitals in America in case you want to know where your particular hospital stacks up:

http://health.usnews.com/sections/health/best-childrens-hospitals

OMNI Postings of 5/30/08

On this date in 1431, Joan of Arc was burned at the stake.  After it was over, it was discovered that, while Joan was well-done, the stake (steak?) was only medium-rare.
but I digress…
1)  This is an USA Today editorial on the sad state of our country’s ERs.  It advocates ACEP’s ideas on how to improve the situation. They include the following recommendations:  1)  Move admitted patients from the ER to other departments, even when beds are not available; 2)  Spread the scheduling of elective surgeries through the week, instead of stacking most on Monday through Wednesday; 3) Coordinate the discharge of hospital patients by noon, which helps to open beds.
2)  This is an Op-Ed piece from the head of the AHA who believes only health care reform will cure ER ills.  I wonder what he would say if he had to wait in an ER 3 hours with a toothache?
3)  This is a news report on a study concluding that more care doesn’t translate into longer or better lives.  It just translates into more costs.
4)  A new study shows emergency room patients received an average radiation dose of 45 millisieverts. But 12% of patients received 100 or more millisieverts of radiation during the five-year study period — a dose that exceeds the recommended safety limits and may increase the risk of cancer.  If we were allowed to practice the “art” of emergency medicine instead of “cover-your-ass” emergency medicine, the average radiation dose/patient would plummet faster than the DJIA after oil shoots to $150/barrel.
5)  Meanwhile, there is a group of researchers who care not a whit about cancer-causing ER imaging.  They advocate immediate CT angiography in the ER on chest pain patients.  In their study, during the 30-day follow-up period, none of the patients who had a negative CT died of a cardiovascular event or had a nonfatal MI, implying that the negative scan is sufficient to rule out any danger.  Putting aside the risk of CA, if these results are replicated in future studies, disposition on these patients will be a helluva lot faster than it is now.  A CT protocol can be adopted to not only check for blockage but to check for PE.  Arguably, once the results return as negative, who really cares what’s causing the chest pain.
 A good weekend to all and sundry,
Paul R.

AHA on ERs

USA Today Op-Ed, 5/30/08: 

The professionals in America’s hospital ERs are working on immediate and long-term solutions to the crowded conditions many patients find when they come to the emergency room. With the number of uninsured people increasing and fewer primary care doctors available, more Americans turn to the emergency room for routine care. But waiting times must be reduced.

Many hospitals, physicians and local emergency medical systems monitor available capacity and direct patients to less crowded hospitals. As hospitals rebuild aging ERs, they are adding multiple levels of care to ensure that emergencies are treated by emergency specialists and that non-emergencies are handled in settings much like a doctor’s office. Better coordination of operating room schedules for emergency and elective surgeries, and efforts to make the daily discharging of patients more efficient, can make beds available more quickly for arrivals. No single solution will work in every hospital. But progress is being made in easing crowded conditions and shortening patient waits.

Today’s ER problems often are the result of greater challenges facing the community at large. We must expand health coverage to the 46 million people without it. And we must increase the number and availability of primary care physicians so that everyone, whether insured or not, has access to primary and preventive care.

From the inner city to rural America, emergency rooms must respond to every imaginable illness, injury and disaster. It is what they do. When it comes to facing these long- and short-term challenges, hospitals aren’t waiting for someone else to come up with a solution. They are making changes according to their community’s needs.

But crowded ERs cannot be relieved solely by changes at the hospital door. They are a symptom of the many serious problems challenging our nation’s health and health care — problems that can be solved only by fundamental reform. That is a task that awaits a new president and Congress.

 

Rich Umbdenstock is president and CEO of the American Hospital Association.

USA Today on the State of American ERs

USA Today Editorial, 5/30/08: On the night of her baby’s seizure in February, Brandy Nannini discovered a harsh reality of today’s overtaxed medical system. The ambulance crew that responded to her 911 call refused to take 23-month-old Bella to a nearby Washington, D.C., hospital where her doctor was waiting. The emergency room was so crowded it was closed to new patients. Despite Nannini’s pleas, the ambulance was diverted to suburban Virginia.

1

Bella got to a hospital in time. But Nannini, who has insurance but goes to the ER often because of her child’s seizures, was shocked that emergency rooms could simply close.

They can, and they do. In fact, they have little choice. Once a rare safety valve, “diversions” to other hospitals have become routine. And they are just one symptom of an emergency system that is sick.

Rising health care costs have forced hundreds of hospitals out of business, mostly in poorer areas, putting pressure on those that remain. They, too, are racing to trim costs, and there’s little incentive to focus on ERs, which are not money-makers. So the sickest patients are endangered, and communities are left unprepared for disasters, whether a bus crash, a hurricane or a terror attack.

You don’t need a medical degree to identify the symptoms: Waiting rooms are often standing-room-only, corridors clogged with patients on gurneys. Waiting times are longer, even for heart attack patients: One in four waits nearly an hour to be seen by a doctor. ER patients so sick they’re already admitted to the hospital still could wait hours parked in emergency room corridors for inpatient beds to open up. In a survey last year by the American College of Emergency Physicians (ACEP), 13% of ER doctors said they knew of a patient who died because of that practice.

In a report last month, ACEP called on hospitals to make several common-sense changes to fix the ER mess:

Move admitted patients from the ER to other departments, even when beds aren’t available. That has been standard practice at Stony Brook University Medical Center in New York since 2001 and it benefits everyone, says Peter Viccellio, director of the emergency department. It takes the heat off the ER so doctors there can do their jobs, and patients get the specialized care they need.

Spread the scheduling of elective surgeries through the week, instead of stacking most on Monday through Wednesday. That might annoy surgeons, but it has opened more inpatient beds and alleviated congestion at Boston Medical Center, home to one of the most crowded ERs in the nation.

Coordinate the discharge of hospital patients by noon, which helps to open beds.

Too few hospitals have followed the leaders in making these changes. It’s easier to leave the burden in one spot, the ER, rather than spread the pain around the hospital.

The American Hospital Association prefers to suggest that the crisis is about the uninsured using ERs for primary care and that only “fundamental reform” will help.

That aspect of the problem, while real, is overstated. According to the National Center for Health Statistics, less than 14% of ER patients come for non-urgent needs, while 70% require immediate or semi-urgent care. (The other 16% were not tracked.) Yes, major health care reform is needed, but the ER crisis is one hospitals could ease themselves.

ERs have been at the breaking point for several years, an Institute of Medicine study found in 2006. Bella Nannini, now 2 years old, and millions of others are waiting for hospitals to do something about it.

The down-side of too much care

Seattle Post-Intelligence, 5/30/08:  Too much medical care could be harmful to your health.

That’s what researchers concluded after examining the nations’ hospitals and the care patients receive. Some hospitals and some areas of the country give patients more aggressive care — meaning more tests, longer hospital stays and more procedures — than others. And the extra treatment doesn’t always translate to longer or better lives.

The 2008 Dartmouth Atlas of Health Care study, released Thursday, studied more than 4 million Medicare patients at nearly 3,000 hospitals across the country from 2001 through 2005 during the last two years of life.

The patients were 65 years and older and were treated for the top nine leading causes of death, including congestive heart failure, chronic pulmonary disease, cancer, dementia, coronary artery disease, chronic kidney failure, peripheral vascular disease, diabetes with organ damage and severe chronic liver disease.

The study found that depending on where patients lived and what hospital they went to, there were big discrepancies in how they were treated.

Researchers reasoned all medical care carries some risk, so the longer a patient is hospitalized and the more procedures and tests performed, the greater the risks, in addition to greater costs.

The more resources available at a hospital equaled more care and in turn, more chances for errors and complications, according to the study.

To help consumers better identify which hospitals are more or less aggressive with their care, Consumer Reports magazine launched the Consumer Reports Health Ratings Center, which ranks hospitals and soon will rate other health care providers.

Launched in conjunction with the Dartmouth study, the online tool at ConsumerReportsHealth.org lets consumers compare treatment approaches among hospitals for the nine serious chronic conditions in the study on a scale from 0 percent to 100 percent (the higher the percentage the more aggressive the treatment).

The percentile rank is based on the total number of hospital days and inpatient physician visits over the last two years of life. Next to each of the nearly 3,000 hospitals, there also are the patient out-of-pocket costs over the last two years of life.

For example, hospitals in New York and Los Angeles top the list of most aggressive care, while Scott & White Memorial Hospital in Temple, Texas, is the most conservative.

Seattle ranks on the lower, more conservative end of the spectrum when treating patients.

Of the 18 Seattle-area hospitals listed on the site, larger ones such as Swedish Medical Center, the University of Washington Medical Center and Virginia Mason had higher percentiles. They ranked 44 percent, 33 percent and 29 percent respectively.

Jefferson Healthcare in Port Townsend, St. Francis Hospital in Federal Way and Olympic Medical Center in Port Angeles ranked on the low end at 2 percent and 3 percent.

The numbers tend to be lower because the larger hospitals usually have more complicated cases, often referred to them by the smaller ones, according to the Washington Hospital Association.

The association said it was pleased with where Seattle and Washington as a whole fall on the Consumer Reports rankings, which indicates Seattle patients are getting the care they need and want, but are not getting a lot of unnecessary care.

“If we had any hospitals with exceptionally high scores, I would worry that patients were getting much more care than they needed or wanted,” spokeswoman Cassie Sauer said.

“Spending hours and hours in medical appointments, tests and treatments — particularly when there’s no evidence they will make any difference — could offer false hope, hurt quality of life, and create significant medical bills. I think many Americans assume that more care is better care, but that is certainly not always the case”

 

ON THE WEB

To view the 2008 Dartmouth Atlas

of Health Care study, visit dartmouthatlas.org.

To see the Consumer Reports rankings, visit ConsumerReportsHealth.org.

 

 

CA risk in ER imaging studies

WebMD, 5/29/08:  Emergency room visitors may be exposed to potentially dangerous levels of radiation from X-rays, CT scans, and other tests that may increase their risk of cancer in years to come.Researchers say emergency room physicians do not routinely keep track of the cumulative amount of radiation their patients receive. In fact, until now, they had no way of knowing how much radiation a patient has been exposed to during one or multiple visits.

A new study shows emergency room patients received an average radiation dose of 45 millisieverts. But 12% of patients received 100 or more millisieverts of radiation during the five-year study period — a dose that exceeds the recommended safety limits and may increase the risk of cancer.

“Our research hopefully will affect the habits of physicians who routinely order medical imaging diagnostic studies in their practices,” researcher Timothy Bullard, MD, MBA, of the Orlando Regional Medical Center, says in a news release. “We also hope that our research will further promote the need for electronic medical records with portability and encourage the development of an individual patient cumulative exposure estimate tool.”

In the study, presented this week at the annual meeting of the Society for Academic Emergency Medicine in Washington, D.C., researchers measured the amount of radiation that a random sample of patients at two urban emergency rooms received over the course of five years.

Overall, an average of 10.8 tests involving radiation exposure, such as X-ray, CT scans, and nuclear imaging tests (tests that use small amounts of radioactive material to produce pictures of internal parts of the body not visible on X-rays), were performed on each patient studied.

Nearly two-thirds of these tests were X-rays (63%), 26% were CT scans, 5% were nuclear studies, and 2% were mammography.

Researchers found more than 70% of ER-related radiation exposure came from three primary types of diagnostic imaging tests: CT scans of the abdomen and pelvis, nuclear imaging of the heart, and CT scans of the chest.

They say if these findings apply to the average emergency room visitor nationwide, a substantial number of people may be at increased risk of developing cancer during their lifetime because of excessive radiation exposure from diagnostic ER testing.

They estimate that an additional six cancers above the national average would be attributable to radiation exposure in this population.

CT Angiographies in the ER

In patients with potential acute coronary syndromes, a negative CT angiogram means they can be sent home safely, a researcher said here.

That finding comes from a study of patients considered to be at low risk for heart attack who were treated in a hospital emergency department for chest pain, Anne Marie Chang, M.D., of the University of Pennsylvania, reported at the Society for Academic Emergency Medicine meeting.

Dr. Chang and colleagues assigned the patients to either an immediate coronary computerized tomographic angiography or to CT angiography after a nine- to 12-hour observation period that included tests for coronary biomarkers, Dr. Chang said. 

The bottom line, Dr. Chang said, is that patients whose coronary [CT angiography] is negative are not at risk for cardiovascular death or MI. 

 

“We have shown in our clinical practice,” she said, “that if they have a negative [CT angiogram], you should be able to safely send patients home.” 

 

The procedure has “excellent performance characteristics” when it’s compared to standard coronary angiography, as well as to exercise or pharmacological stress tests. 

 

But it remained unclear if doctors can use the method to stratify low-risk patients, Dr. Chang reported, where low-risk is defined as a Thrombolysis in Myocardial Infarction (TIMI) score of less than two. 

 

To try to answer the question, she and colleagues conducted a prospective evaluation of 568 consecutive patients, with 285 in the immediate CT angiography arm and 283 in the observation-first arm. 

 

Patients with negative tests were sent home. The main outcome was cardiovascular death or myocardial infarction within 30 days, Dr. Chang said. 

 

All told, 476 patients (84%) had a negative coronary CT angiogram and were sent home. 

 

During the 30-day follow-up period, none of them died of a cardiovascular event or had a nonfatal MI, she said, implying that the negative scan is sufficient to rule out any danger. 

 

The study was one of two evaluating aspects of coronary CT angiography presented by Dr. Chang. 

 

The other was a retrospective look at four strategies for evaluating low-risk patients after a doctor determined they should be admitted and tested to rule out acute coronary syndrome. 

 

The four strategies were: 

 

  • Immediate coronary CT angiography in the emergency room for 98 patients, without serial cardiac biomarkers. 
  • Coronary CT angiography and clinical decision unit evaluation with serial cardiac biomarkers for 102 patients. 
  • Clinical decision unit evaluation with serial cardiac biomarkers and stress testing, for 154 patients. 
  • Usual care, defined as admission with serial cardiac biomarkers and hospitalist-directed evaluation, for 289 patients. 

 

The outcomes were actual cost of care, length of stay, diagnosis of coronary disease, and cardiovascular death or MI within 30 days, Dr. Chang said. 

 

Analysis found that the median cost for immediate CT angiography was $1,240 compared with $2,318 for clinical decision unit evaluation with CT angiography, $4,024 for clinical decision unit evaluation and stress testing, and $2, 913 for usual care. The differences were significant at P<0.01, Dr. Chang reported. 

 

Length of stay was 8.1 hours for immediate CT angiography, compared with 20.9 hours for clinical decision unit evaluation with CT angiography, 26.2 for clinical decision unit evaluation and stress testing, and 30.2 for usual care. The differences were, again, significant at P<0.01. 

 

The rate of diagnosis of coronary disease was similar in all four arms, ranging from 5.1% to 6.6%. 

 

However, there were no cardiovascular deaths or MIs within 30 days in the immediate CT angiography arm, compared with 0% and 3.2% for clinical decision unit evaluation with CT angiography, 0.7% and 2.3% for clinical decision unit evaluation and stress testing, and 3.1% and 12.2% for usual care. The differences were significant at P=0.04 for cardiovascular death and P<0.01 for MI. 

 

The cohorts for the two studies overlapped, Dr. Chang said, with some of the patients in the prospective analysis also used in the cost-benefit analysis. Primary source: Society for Academic Emergency Medicine meeting
Source reference:
Chang AM, et al “Coronary computerized tomography for rapid discharge of low risk patients with potential acute coronary syndromes” SAEM Meeting 2008; Abstract 11. 

Additional source: Society for Academic Emergency Medicine meeting
Source reference:
Chang AM, et al “Actual financial comparison of four strategies to evaluate patients with potential acute coronary syndromes” SAEM Meeting 2008; Abstract 12. 

 

Gout & Steroids

The Lancet 2008; 371:1854-1860 

Summary

Background

Non-steroidal anti-inflammatory drugs and colchicine used to treat gout arthritis have gastrointestinal, renal, and cardiovascular adverse effects. Systemic corticosteroids might be a beneficial alternative. We investigated equivalence of naproxen and prednisolone in primary care.

Methods

We did a randomised clinical trial to test equivalence of prednisolone and naproxen for the treatment of monoarticular gout. Primary-care patients with gout confirmed by presence of monosodium urate crystals were eligible. 120 patients were randomly assigned with computer-generated randomisation to receive either prednisolone (35 mg once a day; n=60) or naproxen (500 mg twice a day; n=60), for 5 days. Treatment was masked for both patients and physicians. The primary outcome was pain measured on a 100 mm visual analogue scale and the a priori margin for equivalence set at 10%. Analyses were done per protocol and by intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN14648181.

Findings

Data were incomplete for one patient in each treatment group, so per-protocol analyses included 59 patients in each group. After 90 h the reduction in the pain score was 44·7 mm and 46·0 mm for prednisolone and naproxen, respectively (difference 1·3 mm; 95% CI −9·8 to 7·1), suggesting equivalence. The difference in the size of change in pain was 1·57 mm (95% CI −8·65 to 11·78). Adverse effects were similar between groups, minor, and resolved by 3 week follow-up.

Interpretation

Oral prednisolone and naproxen are equally effective in the initial treatment of gout arthritis over 4 days.

Infection and SIDS

 

The Lancet 2008; 371:1848-1853

Summary

Background

The cause and mechanism of most cases of sudden unexpected death in infancy (SUDI) remain unknown, despite specialist autopsy examination. We reviewed autopsy results to determine whether infection was a cause of SUDI.

Methods

We did a systematic retrospective case review of autopsies, done at one specialist centre between 1996 and 2005, of 546 infants (aged 7–365 days) who died suddenly and unexpectedly. Cases of SUDI were categorised as unexplained, explained with histological evidence of bacterial infection, or explained by non-infective causes. Microbial isolates gathered at autopsy were classified as non-pathogens, group 1 pathogens (organisms usually associated with an identifiable focus of infection), or group 2 pathogens (organisms known to cause septicaemia without an obvious focus of infection).

Findings

Of 546 SUDI cases, 39 autopsies were excluded because of viral or pneumocystis infection or secondary bacterial infection after initial collapse and resuscitation. Bacteriological sampling was done in 470 (93%) of the remaining 507 autopsies. 2079 bacteriological samples were taken, of which 571 (27%) were sterile. Positive cultures yielded 2871 separate isolates, 484 (32%) of which showed pure growth and 1024 (68%) mixed growth. Significantly more isolates from infants whose deaths were explained by bacterial infection (78/322, 24%) and from those whose death was unexplained (440/2306, 19%) contained group 2 pathogens than did those from infants whose death was explained by a non-infective cause (27/243, 11%; difference 13·1%, 95% CI 6·9–19·2, p<0·0001 vs bacterial infection; and 8·0%, 3·2–11·8, p=0·001 vs unexplained). Significantly more cultures from infants whose deaths were unexplained contained Staphylococcus aureus (262/1628, 16%) or Escherichia coli (93/1628; 6%) than did those from infants whose deaths were of non-infective cause (S aureus: 19/211, 9%; difference 7·1%, 95% CI 2·2–10·8, p=0·005; E coli: 3/211, 1%, difference 4·3%, 1·5–5·9, p=0·003).

Interpretation

Although many post-mortem bacteriological cultures in SUDI yield organisms, most seem to be unrelated to the cause of death. The high rate of detection of group 2 pathogens, particularly S aureus and E coli, in otherwise unexplained cases of SUDI suggests that these bacteria could be associated with this condition.